ILY-102

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameILY-102
Drug Alias Namesodium binder (Relypsa)ILY-102
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium metabolism modulators
TargetsUpdating
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesI.L.Y. Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesI.L.Y. SaRelypsa Inc
Active IndicationsN/A
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A